Philips Announces 3‑Year iMODERN Results in 1,146‑Patient Trial
Royal Philips (NYSE:PHG) reported late-breaking 3-year results from the iMODERN trial (n=1,146) showing no significant…
Browsing Tag
NEJM
1 post